Results 271 to 280 of about 687,004 (308)

Spirituality and religion in oncology

Ca-A Cancer Journal for Clinicians, 2013
John R Peteet
exaly  

Two populations of binding sites for muscarinic antagonists in the rat heart.

European Journal of Pharmacology, 1981
E. Hulme, C. Berrie, N. Birdsall, A. Burgen   +3 more
semanticscholar   +1 more source

Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2019
Robert A Smith, Stacey A Fedewa
exaly  

Comparison of affinities of muscarinic antagonists to pre- and postjunctional receptors in the guinea-pig ileum.

European Journal of Pharmacology, 1984
H. Kilbinger, S. Halim, G. Lambrecht, W. Weiler, I. Wessler   +4 more
semanticscholar   +1 more source

Muscarinic Receptor Antagonists

1998
openaire   +1 more source

Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
William M Lydiatt, Snehal G Patel, Brian O'Sullivan   +2 more
exaly  

Adolescent and young adult oncology—past, present, and future

Ca-A Cancer Journal for Clinicians, 2019
Allison G Close, Kimberly D Miller, Louis B Rapkin   +2 more
exaly  

Phenyl-substituted analogues of oxotremorine as muscarinic antagonists.

Journal of Medicinal Chemistry, 1992
B. Nilsson, H. Vargas, Bjoern Ringdahl, U. Hacksell   +3 more
semanticscholar   +1 more source

Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2017
Robert A Smith, Stacey A Fedewa, Otis W Brawley   +2 more
exaly  

Darifenacin, A selective muscarinic M3 antagonist

Pharmacological Research, 1995
R.M. Wallis, R.A. Burges, P.E. Cross, A.R. MacKenzie, D.T. Newgreen, P. Quinn   +5 more
openaire   +1 more source